RU2 Potential Time Savings With Trastuzumab Subcutaneous (SC) Injection Versus Trastuzumab Intravenous (IV) Infusion- Results from Interviews Conducted As Part of a Time-and-Motion Study (TM) Across 17 Sites
Nov 1, 2012, 00:00 AM
10.1016/j.jval.2012.08.489
https://www.valueinhealthjournal.com/article/S1098-3015(12)02202-4/fulltext
Section Title :
Resource Use Research
Section Order :
18
First Page :
A280
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)02202-4&doi=10.1016/j.jval.2012.08.489